InvestorsHub Logo
Followers 14
Posts 2874
Boards Moderated 0
Alias Born 12/23/2014

Re: budge post# 2416

Friday, 09/13/2019 10:08:22 AM

Friday, September 13, 2019 10:08:22 AM

Post# of 2463
@Budge - The migration to and formulation of the drugs for the SubQ market is in its early stages. The proving of a an acceptable safety profile is more a confirmation of what seems obvious. Other studies have shown that the administering of drugs via SubQ results in a more even drug level within the patients. Less spikes and valleys and hopefully less negative side effects.